15588 Federal Register / Vol. 60, No. 57 / Friday, March 24, 1995 / Notices

merchandise. The administrative law

judge considered the fact that this

conduct occurred more than ten years

before, but found that Respondent had

not acknowledged wrongdoing or

expressed any remorse for his

misconduct. Judge Bittner concluded

that Respondent is unable or unwilling

to discharge the responsibilities

inherent in a DEA registration, and

recommended that his application for

registration be denied.

The Deputy Administrator adopts the

opinion and recommended ruling,

findings of fact, conclusions of law and

decision of the administrative law judge

in its entirety. Based on the foregoing,

the Deputy Administrator concludes

that Respondent’s registration is

inconsistent with the public interest.

Accordingly, the Deputy Administrator

of the Drug Enforcement

Administration, pursuant to the

authority vested in him by 21 U.S.C. 823

and 824 and 28 CFR 0.100(b) and 0.104,

hereby orders that the application of

James C. Graham, M.D., be and it hereby

is, denied. This order is effective March

24, 1995.

Dated: March 20, 1995.

Stephen H. Greene,

Deputy Administrator.

[FR Doc. 95–7317 Filed 3–23–95; 8:45 am]

BILLING CODE 4410–09–M

Charles L. Sweet, M.D.; Revocation of

Registration

On November 7, 1994, the Deputy

Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration (DEA), issued an Order

to Show Cause to Charles L. Sweet,

M.D., of 219 Broadway, PO. Box 518,

Fullerton, Nebraska. The Order to Show

Cause proposed to revoke Dr. Sweet’s

DEA Certificate of Registration,

BS2051061, under 21 U.S.C. 824(a)(3),

and deny any pending applications for

renewal of such registration under 21

U.S.C. 823(f).

The Order to Show Cause was served

on Dr. Sweet on November 14, 1994.

More than thirty days have passed since

the Order to Show Cause was received

by Dr. Sweet. The Drug Enforcement

Administration has received no

response from Dr. Sweet or anyone

purporting to represent him.

Pursuant to 21 CFR 1301.54(d), the

Deputy Administrator finds that Dr.

Sweet has waived his opportunity for a

hearing. Accordingly, under the

provisions of 21 CFR 1301.54(e) and

1301.57, the Deputy Administrator

enters his final order in this matter

without a hearing and based on the

investigative file.

The Deputy Administrator finds that

in 1975, Dr. Sweet’s DEA Certificates of

Registration, AS4344951 and

AS4355168 were retired based on his

failure to renew them. As a result of his

failure to renew his DEA registrations,

Dr. Sweet’s Nebraska State controlled

substance registration was revoked on

June 5, 1989. On June 29, 1989, DEA

sent Dr. Sweet a letter of admonition

advising him that he could not handle

controlled substances until he obtained

a DEA registration.

Dr. Sweet subsequently reapplied for

DEA and Nebraska controlled substance

registrations, and in October 1989, Dr.

Sweet was issued DEA Certificate of

Registration, BS2051061, as well as a

Nebraska controlled substance

registration. However, an investigation

by the Nebraska Department of Health,

Bureau of Examining Boards revealed

that between June and October 1989, Dr.

Sweet wrote numerous prescriptions for

controlled substances when he did not

possess either a DEA registration and/or

a Nebraska controlled substance

registration. As a result, on November 8,

1991, Dr. Sweet’s Nebraska controlled

substance registration was revoked. In

addition, effective October 15, 1992, Dr.

Sweet’s state license to practice

medicine and surgery was also revoked.

The Deputy Administrator finds that

as of November 8, 1991, Dr. Sweet’s

license to handle controlled substances

in the State of Nebraska was revoked,

and as a result, he is unable to handle

controlled substances. The Drug

Enforcement Administration cannot

register or maintain the registration of a

practitioner who is not duly authorized

to handle controlled substances in the

state in which he conducts his business.

21 U.S.C. 802(21), 823(f) and 824(a)(3).

This prerequisite has been consistently

upheld. See James H. Nickens, M.D., 57

FR 59847 (1992); Elliott Monroe, M.D.,

57 FR 23246 (1992); Bobby Watts, M.D.,

53 FR 11919 (1988).

Based on the foregoing, it is clear that

Dr. Sweet’s DEA Certificate of

Registration must be revoked.

Accordingly, the Deputy Administrator

of the Drug Enforcement

Administration, pursuant to the

authority vested in him by 21 U.S.C. 823

and 824 and 28 CFR 0.100(b) and 0.104,

hereby orders that DEA Certificate of

Registration, BS2051061, previously

issued to Charles L. Sweet, M.D., be,

and it hereby is, revoked and that any

pending applications for renewal of

such registration be, and they hereby

are, denied. This order is effective April

24, 1995.

Dated: March 20, 1995.

Stephen H. Greene,

Deputy Administrator.

[FR Doc. 95–7318 Filed 3–23–95; 8:45 am]

BILLING CODE 4410–09–M

Office of Justice Programs

[OJP No. 1044 and ZRIN 1121–ZA08]

1995–96 National Institute of Justice

Research Plan

AGENCY: U.S. Department of Justice,

Office of Justice Programs, National

Institute of Justice.

ACTION: Notice of the availability of the

1995–96 National Institute of Justice

Research Plan.

SUMMARY: The National Institute of

Justice (NIJ) is publishing this Notice of

the availability of its 1995–96 National

Institute of Justice Research Plan.

DATES: The deadlines for receipt of

proposals are Thursday, June 15, 1995;

Friday, December 15, 1995; Monday,

June 17, 1996; and Monday, December

16, 1996.

ADDRESSES: Comments should be

addressed to the National Institute of

Justice, 633 Indiana Avenue NW.,

Washington, DC 20531.

FOR FURTHER INFORMATION CONTACT:

Jeremy Travis, Director, National

Institute of Justice, 633 Indiana Avenue

NW., Washington, DC 20531. To obtain

copies of the 1995–96 National Institute

of Justice Research Plan, call the

National Criminal Justice Reference

Service (NCJRS), 1–800–851–3420, Box

6000, Rockville, MD 20850. The Plan is

also available electronically via the

National Criminal Justice Reference

Service Bulletin Board (NCJRS*BBS). If

you have Internet access; telnet to

ncjrsbbs.aspensys.com or gopher to

ncjrs.aspensys.com 71. Users without

Internet access may direct dial to (301)

738–8895. Modems should be set at

9600 Baud and N–8–1. The NIJ Research

Plan is listed under the ‘‘National

Institute of Justice Information’’ menu.

SUPPLEMENTARY INFORMATION: The

following supplementary information is

provided:

Authority

This action is authorized under the

Omnibus Crime Control and Safe Streets

Act of 1968, §§ 201–03, as amended, 42

U.S.C. §§ 3721–23 (1988).

Background

The 1995–96 National Institute of

Justice Research Plan outlines the NIJ

research and evaluation agenda for

1995, provides descriptions of program